Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Ries

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Journal of the American Society of Nephrology : JASN|April 10, 2009
Agalsidase alfa and kidney dysfunction in Fabry diseaseMichael West, Kathy Nicholls, Atul Mehta, et al.
Annals of Neurology|December 11, 2008
Randomized, controlled trial of miglustat in Gaucher's disease type 3Raphael Schiffmann, Edmond J Fitzgibbon, Chris Harris, et al.
Nature|February 25, 2021
Experimental demonstration of the mechanism of steady-state microbunchingXiujie Deng, Alexander Chao, Jörg Feikes, et al.
Vaccines|August 28, 2021
Public Health Leadership in a VUCA World Environment: Lessons Learned during the Regional Emergency Rollout of SARS-CoV-2 Vaccinations in Heidelberg, Germany, during the COVID-19 PandemicChristoph Schulze, Andreas Welker, Anne Kühn, et al.
Pediatrics|September 5, 2006
Enzyme-replacement therapy with agalsidase alfa in children with Fabry diseaseMarkus Ries, Joe T R Clarke, Catharina Whybra, et al.
Human Mutation|March 19, 2005
Thirty-four novel mutations of the GLA gene in 121 patients with Fabry diseaseEllen Schäfer, Karin Baron, Urs Widmer, et al.
Frontiers in Public Health|April 27, 2026
Vaccination gaps in decentralized emergency response: understanding immunization barriers among volunteer firefighters. A cross-sectional mixed methods studyAndrea Baron, Laura Over-Müller, Swantje Brandt, et al.
Studies in Health Technology and Informatics|September 7, 2011
IT infrastructure components to support clinical care and translational research projects in a comprehensive cancer centerHans-Ulrich Prokosch, Markus Ries, Alexander Beyer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 18, 2013
Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfaRaphael Schiffmann, Markus Ries, Derek Blankenship, et al.
Pediatrics|February 17, 2005
Pediatric Fabry diseaseMarkus Ries, Surya Gupta, David F Moore, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Journal of the American Society of Nephrology : JASN|April 10, 2009
Agalsidase alfa and kidney dysfunction in Fabry diseaseMichael West, Kathy Nicholls, Atul Mehta, et al.
Annals of Neurology|December 11, 2008
Randomized, controlled trial of miglustat in Gaucher's disease type 3Raphael Schiffmann, Edmond J Fitzgibbon, Chris Harris, et al.
Nature|February 25, 2021
Experimental demonstration of the mechanism of steady-state microbunchingXiujie Deng, Alexander Chao, Jörg Feikes, et al.
Vaccines|August 28, 2021
Public Health Leadership in a VUCA World Environment: Lessons Learned during the Regional Emergency Rollout of SARS-CoV-2 Vaccinations in Heidelberg, Germany, during the COVID-19 PandemicChristoph Schulze, Andreas Welker, Anne Kühn, et al.
Pediatrics|September 5, 2006
Enzyme-replacement therapy with agalsidase alfa in children with Fabry diseaseMarkus Ries, Joe T R Clarke, Catharina Whybra, et al.
Human Mutation|March 19, 2005
Thirty-four novel mutations of the GLA gene in 121 patients with Fabry diseaseEllen Schäfer, Karin Baron, Urs Widmer, et al.
Frontiers in Public Health|April 27, 2026
Vaccination gaps in decentralized emergency response: understanding immunization barriers among volunteer firefighters. A cross-sectional mixed methods studyAndrea Baron, Laura Over-Müller, Swantje Brandt, et al.
Studies in Health Technology and Informatics|September 7, 2011
IT infrastructure components to support clinical care and translational research projects in a comprehensive cancer centerHans-Ulrich Prokosch, Markus Ries, Alexander Beyer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 18, 2013
Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfaRaphael Schiffmann, Markus Ries, Derek Blankenship, et al.
Pediatrics|February 17, 2005
Pediatric Fabry diseaseMarkus Ries, Surya Gupta, David F Moore, et al.
Pageof 10